Reply to: Letter re: Efficacy of isolated limb perfusion (ILP) in patients with Merkel cell carcinoma: A multicenter experience

Eur J Surg Oncol. 2019 Jun;45(6):1122-1123. doi: 10.1016/j.ejso.2019.02.020. Epub 2019 Feb 16.

Authors

Linde M van Veenendaal¹, Max F Madu², Margot E T Tesselaar¹, Cornelis Kees Verhoef³, Dirk J Grünhagen³, Alexander C J van Akkooi⁴

Affiliations

¹ Department of Medical Oncology, Netherlands Cancer Institute, the Netherlands.
² Department of Surgical Oncology, Netherlands Cancer Institute, the Netherlands.
³ Department of Surgical Oncology, Erasmus MC Cancer Institute, the Netherlands.
⁴ Department of Surgical Oncology, Netherlands Cancer Institute, the Netherlands. Electronic address: a.v.akkooi@nki.nl.

PMID: 30808525
DOI: 10.1016/j.ejso.2019.02.020

No abstract available

Publication types

Letter
Comment

MeSH terms

Carcinoma, Merkel Cell*
Chemotherapy, Cancer, Regional Perfusion
Humans
Melphalan
Skin Neoplasms*

Substances

Melphalan